Mackenzie, Scott C. http://orcid.org/0000-0001-5823-4334
Stephen, Jacqueline http://orcid.org/0000-0003-4997-3017
Williams, Linda http://orcid.org/0000-0002-6317-1718
Daniels, Jane http://orcid.org/0000-0003-3324-6771
Norrie, John http://orcid.org/0000-0001-9823-9252
Becker, Christian M. http://orcid.org/0000-0002-9870-9581
Byrne, Dominic
Cheong, Ying http://orcid.org/0000-0001-7687-4597
Clark, T. Justin http://orcid.org/0000-0002-5943-1062
Cooper, Kevin G. http://orcid.org/0000-0003-1486-0071
Cox, Emma
Doust, Ann M. http://orcid.org/0000-0001-8726-7186
Fernandez, Priscilla
Hawe, Jeremy
Holland, Tom http://orcid.org/0000-0001-5727-0659
Hummelshoj, Lone http://orcid.org/0000-0003-1490-7802
Jackson, Louise J. http://orcid.org/0000-0001-8492-0020
King, Kathleen
Maheshwari, Abha http://orcid.org/0000-0002-3652-2447
Martin, Dan C.
Sutherland, Lauren http://orcid.org/0000-0001-5465-8586
Thornton, Jim http://orcid.org/0000-0001-9764-6876
Vincent, Katy http://orcid.org/0000-0001-9249-2492
Vyas, Sanjay
Horne, Andrew W. http://orcid.org/0000-0002-9656-493X
Whitaker, Lucy H. R. http://orcid.org/0000-0002-7678-6551
Funding for this research was provided by:
Health Technology Assessment Programme (NIHR129801)
Article History
Received: 21 April 2023
Accepted: 18 May 2023
First Online: 22 June 2023
Declarations
:
: Ethical approval for this trial was obtained on 27 January 2021 from the East of Scotland Research Ethics Committee (NHREC 20/ES/0127). Written or verbal (where participants are consented via telephone/video call) informed consent to participate will be obtained from all participants.
: The model consent form for this trial is available from the corresponding author upon reasonable request.
: CMB has received research funding from Bayer Healthcare and has done consultancy for Myovant, ObsEva, Gedeon Richter and Theramex. YC has received honoraria for medical advisory from Merck, Ferring, Nordic Pharma and Abbot and research funding from Merck and Geurbet. AM has received funding to attend meetings and honoraria for speaking at educational events by Ferring, Merck, Cook Medical, Geodeon Ricter and Pharmasure. DCM has received legal expert witness fees from Lowenthal & Abrams, P.C. (Bala Cynwyd, PA) and funding to attend annual scientific meetings by EndoFound (Endometriosis Foundation of America) and the American Society of Reproductive Medicine (ASRM) as the 2022 recipient of the Society of Reproductive Surgeons (SRS) award recipient (a monetary award by the ASRM accompanied the SRS award). KV has received research funding from Bayer Healthcare and honoraria for consultancy for Bayer Healthcare, AbbVie, Eli Lilly and Reckitts. AWH has received honoraria for consultancy for Roche Diagnostics and Gesynta. AWH and LHRW have received research funding from Roche Diagnostics. SCM, KV, AWH and LHRW are listed as co-inventors on a UK Patent Application (No. 2217921.2) relating to the use of a genetic test to determine efficacy of gabapentin for chronic pelvic pain treatment. The other authors declare no conflict of interest pertaining to this manuscript.